Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.

Narita M, Kuroha T, Watanabe N, Hashimoto S, Tsuchiyama J, Tochiki N, Saitoh A, Satoh N, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M.

Acta Haematol. 2008;120(2):91-9. doi: 10.1159/000165510. Epub 2008 Oct 24.

PMID:
18948686
2.

Identification of cord blood dendritic cells as an immature CD11c- population.

Sorg RV, Kögler G, Wernet P.

Blood. 1999 Apr 1;93(7):2302-7.

PMID:
10090940
3.

A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cells.

Narita M, Watanabe N, Yamahira A, Hashimoto S, Tochiki N, Saitoh A, Kaji M, Nakamura T, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M.

Leuk Res. 2009 Sep;33(9):1224-32. doi: 10.1016/j.leukres.2009.03.047. Epub 2009 May 13.

PMID:
19443030
4.

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts.

Chaperot L, Perrot I, Jacob MC, Blanchard D, Salaun V, Deneys V, Lebecque S, Brière F, Bensa JC, Plumas J.

Eur J Immunol. 2004 Feb;34(2):418-26.

5.

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadié M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC; GOELAMS and GEIL study.

Br J Haematol. 2009 Jun;145(5):624-36. doi: 10.1111/j.1365-2141.2009.07679.x. Epub 2009 Apr 8.

PMID:
19388928
6.

Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.

Gopcsa L, Banyai A, Jakab K, Kormos L, Tamaska J, Matolcsy A, Gogolak P, Rajnavolgyi E, Paloczi K.

Eur J Haematol. 2005 Oct;75(4):346-51.

PMID:
16146542
7.

Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies.

Béné MC, Feuillard J, Jacob MC; Groupe d'Etude Immunologique des Leucémies.

Semin Hematol. 2003 Jul;40(3):257-66. Review.

PMID:
12876674
8.

Allogeneic HLA-matched donor dendritic cells loaded with patient leukemic blasts preferentially induce CD4-positive leukemia-reactive donor lymphocytes.

Thomas-Kaskel AK, Portugal TG, Herchenbach D, Houet L, Veelken H, Finke J.

Acta Haematol. 2007;117(4):226-35. Epub 2007 Feb 14.

PMID:
17308369
9.

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.

Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P.

Blood. 2005 Feb 1;105(3):1256-64. Epub 2004 Sep 23.

PMID:
15388576
10.

Dendritic cell vaccines for leukemia patients.

Schmitt A, Hus I, Schmitt M.

Expert Rev Anticancer Ther. 2007 Mar;7(3):275-83. Review.

PMID:
17338648
11.

Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.

Koyama M, Hashimoto D, Aoyama K, Matsuoka K, Karube K, Niiro H, Harada M, Tanimoto M, Akashi K, Teshima T.

Blood. 2009 Feb 26;113(9):2088-95. doi: 10.1182/blood-2008-07-168609. Epub 2009 Jan 14.

PMID:
19144988
12.
13.

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G; Hellenic Dendritic Cell Leukemia Study Group.

Leuk Res. 2010 Apr;34(4):438-46. doi: 10.1016/j.leukres.2009.09.006. Epub 2009 Sep 29.

PMID:
19793612
14.

Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia.

Tecchio C, Colato C, Bonifacio M, Krampera M, Maluta S, Pizzolo G, Girolomoni G.

Oncologist. 2009 Dec;14(12):1205-8. doi: 10.1634/theoncologist.2009-0184. Epub 2009 Nov 25.

15.

Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.

Troeger A, Meisel R, Moritz T, Dilloo D.

Bone Marrow Transplant. 2005 Mar;35 Suppl 1:S59-64. Review.

PMID:
15812533
16.

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D.

Blood. 2003 Jun 15;101(12):5007-9. Epub 2003 Feb 6.

PMID:
12576313
17.

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

Garnache-Ottou F, Feuillard J, Saas P.

Br J Haematol. 2007 Feb;136(4):539-48. Review.

PMID:
17367408
18.

Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05).

Watanabe N, Narita M, Yamahira A, Nakamura T, Tochiki N, Saitoh A, Kaji M, Hashimoto S, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M.

Leuk Res. 2010 Nov;34(11):1517-24. doi: 10.1016/j.leukres.2010.03.002. Epub 2010 Mar 24.

PMID:
20338639
19.

Derivation of leukemic plasmacytoid dendritic cells coexpressing a progenitor cell surface antigen, CD117, without interferon-alpha production.

Takeda T, Hayashida M, Kadowaki N, Takeoka K, Fukuda M, Sakurai Y.

Asian Pac J Allergy Immunol. 2007 Mar;25(1):91-8.

20.

T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.

Claus JA, Brady MT, Lee J, Donohue KA, Sait SN, Ferrone S, Wetzler M.

Cancer Immunol Immunother. 2006 Feb;55(2):160-5. Epub 2005 Jul 12.

PMID:
16010586

Supplemental Content

Support Center